Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Life Studies
100%
Quality of Life
100%
Sublingual Immunotherapy
100%
GRAZAX
100%
Immunotherapy Treatment
100%
Asthma
66%
Real-life Setting
66%
Adverse Events
33%
Symptom Score
33%
First Month
33%
Adult Patients
33%
Tolerability
33%
First Year
33%
Respiratory Allergy
33%
Allergen
33%
Immunological Tolerance
33%
Pediatric Patients
33%
Medication Adherence
33%
Allergic Rhinoconjunctivitis
33%
Lost to Follow-up
33%
Non-interventional
33%
Life Safety
33%
Adherence Rate
33%
Home Administration
33%
Grass Pollen Season
33%
Allergy Immunotherapy
33%
Period Estimation
33%
Global Health Challenges
33%
Quality of Life Score
33%
Treatment Period
33%
Allergen Immunotherapy
33%
Immunology and Microbiology
Sublingual Immunotherapy
100%
Grass Pollen Vaccine
100%
Asthma
66%
Immune Tolerance
33%
Immunotherapy
33%
Grass Pollen
33%
Allergen
33%
Allergen Immunotherapy
33%
Nose
33%
Global Health
33%
Allergy
33%
Allergic Disease
33%
Pharmacology, Toxicology and Pharmaceutical Science
Immunotherapy
100%
Grass Pollen Vaccine
100%
Asthma
50%
Allergen
50%
Adverse Event
25%
Tolerability
25%
Rhinoconjunctivitis
25%
Diseases
25%
Allergy
25%
Allergic Disease
25%
Psychology
Quality of Life
100%
Adherence to Treatment
33%